Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome
Open accessThe DOI matches its Crossref record; 88 of the 92 references it cites were found in a registry or an index; 22 of the 77 sources its claims cite were checked for support.
Abstract
Context: Late-night salivary cortisol (LNSC) measured by enzyme immunoassay (EIA-F) is a first-line screening test for Cushing syndrome (CS) with a reported sensitivity and specificity of >90%. However, liquid chromatography-tandem mass spectrometry, validated to measure salivary cortisol (LCMS-F) and cortisone (LCMS-E), has been proposed to be superior diagnostically. Objective, Setting, and Main Outcome Measures: Prospectively evaluate the diagnostic performance of EIA-F, LCMS-F, and LCMS-E in 1453 consecutive late-night saliva samples from 705 patients with suspected CS. Design: Patients grouped by the presence or absence of at least one elevated salivary steroid result and then subdivided by diagnosis. Results: We identified 283 patients with at least one elevated salivary result; 45 had an established diagnosis of neoplastic hypercortisolism (CS) for which EIA-F had a very high sensitivity (97.5%). LCMS-F and LCMS-E had lower sensitivity but higher specificity than EIA-F. EIA-F had poor sensitivity (31.3%) for adrenocorticotropic hormone (ACTH)-independent CS (5 patients with at least 1 and 11 without any elevated salivary result). In patients with Cushing disease (CD), most nonelevated LCMS-F results were in patients with persistent/recurrent CD; their EIA-F levels were lower than in patients with newly diagnosed CD. Conclusions: Since the majority of patients with ≥1 elevated late-night salivary cortisol or cortisone result did not have CS, a single elevated level has poor specificity and positive predictive value. LNSC measured by EIA is a sensitive test for ACTH-dependent Cushing syndrome but not for ACTH-independent CS. We suggest that neither LCMS-F nor LCMS-E improves the sensitivity of late-night EIA-F for CS.
Overview
CoChat Summary
TL;DR
In 1453 late-night saliva samples from 705 patients with suspected Cushing syndrome, EIA cortisol (EIA-F) was highly sensitive for ACTH-dependent Cushing syndrome but had poor specificity and positive predictive value. LC-MS/MS cortisol and cortisone did not improve sensitivity and were less sensitive than EIA-F for ACTH-dependent disease, while all assays performed poorly for ACTH-independent adrenal Cushing syndrome.
Key findings
- Among 40 patients with ACTH-dependent Cushing syndrome, EIA-F had sensitivity 97.5%, specificity 69.3%, PPV 16.8%, and NPV 99.8%; LCMS-F had sensitivity 67.5% and specificity 84.6%; LCMS-E had sensitivity 92.5% and specificity 76.2%.
- For ACTH-independent adrenal Cushing syndrome (16 patients: 5 with ≥1 elevated salivary steroid and 11 without), EIA-F sensitivity was 31.3%, LCMS-F 25.0%, and LCMS-E 18.8%; PPVs were 2.5%, 4.0%, and 2.0%, respectively.
- In 35 patients with Cushing disease, false-negative results below assay cutoffs occurred in 12/35 (34%) by LCMS-F, 3/35 (9%) by LCMS-E, and 1/35 (3%) by EIA-F; most nonelevated LCMS-F results were in patients with persistent/recurrent disease.
- Of 283 patients with at least one elevated salivary result, only 45 had proven Cushing syndrome; 238 did not have proven CS, and most false-positive results were by EIA-F.
Methods
- Prospective collection of 1453 consecutive late-night salivary samples from 705 patients ordered as clinical care at Wisconsin Diagnostic Laboratories during calendar year 2019; samples were tested by FDA-cleared EIA-F and by LC-MS/MS for cortisol (LCMS-F) and cortisone (LCMS-E).
- Patients were grouped by presence or absence of at least one elevated salivary steroid result using cutoffs EIA-F ≥3.3 nmol/L, LCMS-F ≥2.8 nmol/L, and LCMS-E ≥8.7 nmol/L; all 283 patients with any abnormal result and 121 randomly selected patients with all normal results underwent in-depth medical record review.
- Diagnostic performance was calculated with MEDCALC; continuous data were compared by Mann-Whitney rank sum or Kruskal-Wallis tests and categorical data by chi-square, with P < 0.05 considered significant.
Limitations
- The paper states it did not address the reasons for clinical suspicion of CS, so pretest probability could not be evaluated; it also notes dependence on cutoffs established contemporaneously in healthy subjects and that results close to any cutoff require clinical context.
- The paper states the study is limited by the relatively small number of patients, particularly for conclusions about recurrent Cushing disease.
- Evident from the text: this was a single-center study, and 20 of 31 patients without elevated salivary results could not be evaluated because extramural medical records were unavailable.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Number of Cushing disease patients (N = 35) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values are from chi-square analysis.](https://figures.cochat.ai/paper-figures/89709a06ce7e4f7ba6b98073332a1dc6/prospective-evaluation-of-late-night-salivary-cortisol-and-cortisone-by-eia-and-figure-3.jpg)
![Figure 4. Number of Cushing disease patients with de novo Cushing disease (N = 12) and patients with recurrent/persistent Cushing disease (N = 23) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values indicate comparison of LC-MS/MS cortisol vs other 2 analytes.](https://figures.cochat.ai/paper-figures/bad97cfee37d4b4c8bf868f09246cc5b/prospective-evaluation-of-late-night-salivary-cortisol-and-cortisone-by-eia-and-figure-4.jpg)

Verification
Claims the paper makes
16 Valid · 2 Not valid · 15 Not checked · 79 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“this study was dependent on the accuracy of the cutoffs we established contemporaneously in healthy subjects [26]”
§ Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome > Discussion
What the sources say
- Supportedcites [26] Raff, 2019, Bedtime salivary cortisol and cortisone by LC-MS/MS in healthy adult subjects: evaluation of sampling time, J Endocr Soc. source
The Methods describe the healthy adult subjects, and the Results report upper limits of normal calculated from their samples. The Discussion identifies the study’s bedtime LC-MS/MS cortisol cutoff. The statement that the citing study depended on those cutoffs is the citing authors’ own assessment, not a finding attributed to this source. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Late-night salivary cortisol (LNSC) measured by enzyme immunoassay (EIA-F) is a first-line screening test for Cushing syndrome (CS) with a reported sensitivity and specificity of >90%.”
- Also stated in: § Discussion · boosted
“We and others have demonstrated that, using relatively nonspecific immunoassays, the sensitivity and specificity of this test exceeds 90% and is as high as 95% to 97% [47, 53].”
§ Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome > Abstract > Context
What the sources say
- Not checked — no full text of the sourcecites [47] Carroll, 2009, Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis, Endocr Pract. source
- Partly supportedcites [53] Galm, 2020, Accuracy of laboratory tests for the diagnosis of Cushing syndrome, J Clin Endocrinol Metab. sourceExperimental — accuracy not yet measured
The Results report sensitivity of 95.9% and specificity of 93.0% for late-night salivary cortisol measured by immunoassay. They do not give separate accuracy estimates for enzyme immunoassay (EIA-F), so the assay-specific part of the claim is not established by those figures. (LLM, conf=0.84)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · boosted
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“most studies have found that LNSC (regardless of assay method) has a poor sensitivity in patients with mild cortisol excess (formerly known as subclinical CS) [20, 56, 62-76]”
§ Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome > Discussion
What the sources say
- Not checked — no full text of the sourcecites [20] Delivanis, 2019, Modern management of mild autonomous cortisol secretion, Clin Pharmacol Ther. source
- Not checked — no full text of the sourcecites [56] Ceccato, 2018, Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma, Endocrine. source
- Not checked — no full text of the sourcecites [62] Ceccato, 2017, First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS, J Endocrinol Invest. source
- Not checked — no full text of the sourcecites [63] Ceccato, 2013, Performance of salivary cortisol in the diagnosis of Cushing’s syndrome, adrenal incidentaloma, and adrenal insufficiency, Eur J Endocrinol. source
- Partly supportedcites [64] Fassnacht, 2016, Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors, Eur J Endocrinol. sourceExperimental — accuracy not yet measured
The Reasoning section says that a few studies suggest poor performance of late-night salivary cortisol in patients with adrenal incidentalomas. It does not say that most studies found poor sensitivity, or that the finding holds regardless of assay method; a response to comment #28 describes the data as conflicting. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [65] Masserini, 2009, The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma, Eur J Endocrinol. source
- Partly supportedcites [66] Nieman, 2010, Approach to the patient with an adrenal incidentaloma, J Clin Endocrinol Metab. sourceExperimental — accuracy not yet measured
The Background section reports 23% sensitivity for late-night salivary cortisol in the largest study of patients with adrenal incidentalomas and subclinical hypercortisolism. But it says the test had been studied in few patients and that smaller series found it useful; it does not establish that most studies found poor sensitivity regardless of assay method. No page number is available in our copy. (LLM, conf=0.88)
- Partly supportedcites [67] Nunes, 2009, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients, J Clin Endocrinol Metab. sourceExperimental — accuracy not yet measured
The Results section reports poor performance for detecting subclinical cortisol-secreting adenomas, with sensitivity around 77%, and the Discussion says salivary cortisol has limitations in subclinical Cushing’s syndrome. But sensitivity for mild recurrence of Cushing’s disease was 84.6–90%, and this paper does not establish that poor sensitivity holds regardless of assay method or across most studies. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [68] Palmieri, 2013, The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism, Eur J Endocrinol. source
- Not checked — no full text of the sourcecites [69] Reincke, 2000, Subclinical Cushing’s syndrome, Endocrinol Metab Clin North Am. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These tests were ordered by endocrinologists, endocrine surgeons, advanced practice providers, and primary care physicians making it more representative of the real world, rather than studies from only tertiary referral centers with a focus on CS [47, 53, 54].”
§ Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome > Discussion
What the sources say
- Not checked — no full text of the sourcecites [47] Carroll, 2009, Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis, Endocr Pract. source
- Partly supportedcites [53] Galm, 2020, Accuracy of laboratory tests for the diagnosis of Cushing syndrome, J Clin Endocrinol Metab. sourceExperimental — accuracy not yet measured
The Discussion says most studies in the review were performed in academic settings, supporting the contrast with less routine clinical settings. It does not say those studies were only from tertiary referral centers or establish that the citing study’s sample is more representative. The clinician mix describes the citing authors’ own study, not Galm et al.’s review. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [54] Ceccato, 2019, The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome: a real-life prospective study, J Endocrinol Invest. source
plainstates a causen = 705- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“salivary cortisone is typically higher than salivary cortisol due to the expression of 11-beta-hydroxysteroid dehydrogenase (11βHSD) type 2 in the salivary gland”
§ Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome > Abstract > Conclusions
What the sources say
- Not checked — no full text of the sourcecites [28] Miller, 2013, Comparison of salivary cortisol as measured by different immunoassays and tandem mass spectrometry, Psychoneuroendocrinology. source
- Supportedcites [29] Casals, 2020, Cortisol measurements in Cushing’s syndrome: immunoassay or mass spectrometry?, Ann Lab Med. source
The Salivary Cortisol—Immunoassay measurements section (page unavailable) says that 11β-hydroxysteroid dehydrogenase type 2 converts cortisol to cortisone after cortisol enters saliva, producing cortisone levels four to nine times higher than cortisol levels. This supports the claimed mechanism and relative levels, although the passage does not explicitly state that the enzyme is expressed in the salivary gland. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [30] Perogamvros, 2010, Salivary cortisone is a potential biomarker for serum free cortisol, J Clin Endocrinol Metab. source
- Not checked — no full text of the sourcecites [31] Perogamvros, 2009, Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions, J Chromatogr B Analyt Technol Biomed Life Sci. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims · 4 with their cited sources checked
Create a free account to see all 112 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 28
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LNSC is well-established as a first-line screening test for patients with CS (7–10).”
From The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism (2022) · cites this paper as [9]
In the citing paper
“Multiple sequential LNSC measurements are very useful to investigate diagnostically challenging patients with cyclic Cushing’s disease.”
From Late-night salivary cortisol and cortisone should be the initial screening test for cushing's syndrome (2022) · cites this paper as [23]
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“Late-night salivary cortisol (LNSC) measured by immunoassay is a useful and simple means to screen patients for suspected hypercortisolism and has been recommended by expert guidelines as an important first-line diagnostic test [24, 25].”
BackgroundMethodSelf-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 2×
“This is not surprising, since most studies have found that LNSC (regardless of assay method) has a poor sensitivity in patients with mild cortisol excess (formerly known as subclinical CS) [20, 56, 62-76].”
BackgroundDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 1×
“Neoplastic hypercortisolism is often responsible for cardiometabolic problems, including obesity, diabetes, hypertension, and low bone density, as well as significant neurocognitive and neuropsychiatric challenges [1-16].”
BackgroundSelf-citationTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270 · cited 1×
“The therapeutic landscape with surgery, radiotherapy, and pharmacotherapy has improved dramatically over the past 30 years for CS and has resulted in better patient outcomes [23].”
BackgroundSelf-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840 · cited 1×
“Neoplastic hypercortisolism is often responsible for cardiometabolic problems, including obesity, diabetes, hypertension, and low bone density, as well as significant neurocognitive and neuropsychiatric challenges [1-16].”
BackgroundAME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V, Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 520 · cited 1×
“This is not surprising, since most studies have found that LNSC (regardless of assay method) has a poor sensitivity in patients with mild cortisol excess (formerly known as subclinical CS) [20, 56, 62-76].”
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419 · cited 1×
“Patients with CS have an increased standard mortality ratio that may be reduced by effective therapy [17-22].”
BackgroundClayton, R. N., Raskauskiene, D., Reulen, R. C., & Jones, P. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1942 · Cited by 374 · cited 1×
“Patients with CS have an increased standard mortality ratio that may be reduced by effective therapy [17-22].”
Background
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Cortisol Immunosensors: A Literature Review
Karachaliou, C., Koukouvinos, G., Goustouridis, D., Raptis, I., Kakabakos, S. E., Petrou, P. S., & Livaniou, E. (2023) · Biosensors · doi:10.3390/bios13020285 · Cited by 75
Diagnostic workup of Cushing’s syndrome
Balomenaki, M., Margaritopoulos, D., Vassiliadi, D. A., & Tsagarakis, S. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13111 · Cited by 45
DeLozier, O. M., Dream, S. Y., Findling, J. W., Carroll, T. B., Evans, D. B., & Wang, T. S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab698 · Cited by 42
Self-citation
Metadata
- Authors
- Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H.
- Affiliations
- Medical College of Wisconsin (US)
- Aurora St. Luke's Medical Center (US)
- Corresponding author
- Raff, Hershel
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2020-07-24
- Volume
- 4
- Issue
- 10
- Pages
- bvaa107-bvaa107
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC7480956
- OpenAlex
- W3044928262
- Semantic Scholar
- 4ed68b1b0e39a57b7a7a8f00613414b800c1d064
- Cited by
- 36
- References
- 92
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 7 · 2020: 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Advocate Aurora Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- Cushing's syndrome, late-night salivary cortisol, salivary cortisone, enzyme immunoassay, liquid chromatography-tandem mass spectrometry, diagnostic accuracy, Cushing's disease, ACTH-independent Cushing's syndrome, screening sensitivity and specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome. https://app.cochat.ai/papers/10.1210/jendso/bvaa107
- The paper
- Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020). Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaa107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.